US Sunshine Act

US Sunshine Act : Check your 2015 Open Payments data

Pharma Compliance Info US Sunshine Act : Check your 2015 Open Payments data US Sunshine Act

By Shantanu Agrawal, M.D, Deputy Administrator and Director of CMS’ Center for Program Integrity The Centers for Medicare & Medicaid Services’ continues to publish data from applicable manufacturers and group purchasing organizations (GPOs) about payments they make to physicians and teaching hospitals on its website, https://openpaymentsdata.cms.gov/. We’re pleased that the public has searched Open Payments data more than 6.3 million times. Doctors, teaching hospitals and others receiving payments or other transfers of value that are sent to us from reporting entities, should take steps to ensure that this information about you, your related research, ownership, and other financial concerns are …

Read More »

U.S. Seeks Records of 80,000 Novartis `Sham’ Events for Doctors

Pharma Compliance Info U.S. Seeks Records of 80,000 Novartis `Sham' Events for Doctors US Sunshine Act

The U.S. is asking Novartis AG to provide records of about 80,000 “sham” events in which the government says doctors were wined and dined so they would prescribe the company’s cardiovascular drugs to their patients. The Swiss drugmaker and the Manhattan U.S. Attorney are engaged in a whistle-blower lawsuit that alleges Novartis provided illegal kickbacks to health-care providers through bogus educational programs at high-end restaurants and sports bars where the drugs were barely discussed. In a filing Friday, the U.S. said it needs Novartis to provide information to support its allegation that the company defrauded federal health-care programs of hundreds …

Read More »

Compliance Officers as Chief Data Analyst

Pharma Compliance Info Compliance Officers as Chief Data Analyst US Sunshine Act

March 18, 2016 by Thomas Sullivan. With the US Sunshine reporting data fast approaching March 31, compliance teams are heads down in getting the spend records collected, audited and ready for final reporting. The frenzy of systems issues (both internal and CMS), personnel challenges and vendor management makes the race to the finish line a close call for most compliance team. How does one take a break to analyze the data before it goes in for submission? What are the risks for submitting data in the public domain without a pre-audit and analytical review? After conversations with a variety of …

Read More »

Now There’s Proof: Docs Who Get Company Cash Tend to Prescribe More Brand-Name Meds

Pharma Compliance Info Now There’s Proof: Docs Who Get Company Cash Tend to Prescribe More Brand-Name Meds US Sunshine Act

This story was co-published with NPR, the Boston Globe and the Tampa Bay Times. Doctors have long disputed that the payments they receive from pharmaceutical companies have any relationship to how they prescribe drugs. There’s been little evidence to settle the matter — until now. A ProPublica analysis has found for the first time that doctors who receive payments from the medical industry do indeed tend to prescribe drugs differently than their colleagues who don’t. And the more money they receive, on average, the more brand-name medications they prescribe. We matched records on payments from pharmaceutical and medical device makers …

Read More »

Mining Open Payments Spend Data: Managing the Risk of Transparency

Pharma Compliance Info Mining Open Payments Spend Data: Managing the Risk of Transparency US Sunshine Act

At a Food and Drug Law Institute webinar last week, Robin Usi, the Director for the Division of Data & Informatics (DDI), in the Data Sharing & Partnership Group of the CMS Center for Program Integrity, made clear that accuracy matters in the reporting of spend data to CMS pursuant to the Physician Payments Sunshine Act. She further stated that CMS is working to identify inaccurate data reporters and that reporters of inaccurate data are prime targets for agency audit and/or compliance actions. Government enforcers, private plaintiffs and even investigative reporters are mining this data to make the case that …

Read More »

This week is Sunshine Week 2016

Pharma Compliance Info This week is Sunshine Week 2016 US Sunshine Act

This week is Sunshine Week 2016, a national initiative to promote a dialogue about the importance of open government and freedom of information. Additionally, this year also marks the 50th anniversary of the Freedom of Information Act (FOIA). On September 13, 1976, President Ford signed S.5, the Government in the Sunshine Act. This act required multiheaded agencies, including independent regulatory agencies, to hold meetings open to the public unless any of 10 specific reasons for holding closed meetings is present. It also amended FOIA to narrow agencies’ authority to withhold information from the public. “In a democracy the public has …

Read More »